Lee, Casey S.
Chen, Sisi
Berry, Corbett T. http://orcid.org/0000-0001-9348-2034
Kelly, Andre R.
Herman, Patrick J.
Oh, Sangwook
O’Connor, Roddy S.
Payne, Aimee S. http://orcid.org/0000-0001-9389-7918
Ellebrecht, Christoph T. http://orcid.org/0000-0001-7656-0491
Article History
Received: 29 September 2022
Accepted: 22 July 2024
First Online: 28 August 2024
Competing interests
: C.T.E.—equity (Cabaletta Bio), patent licensing (Cabaletta Bio, Novartis). A.S.P.—equity, payments, research grants (Cabaletta Bio), patent licensing (Cabaletta Bio, Novartis), consultant (Janssen). S.O.—patent licensing (Cabaletta Bio). R.O.C.—equity (Nucleus Biologics), research grant (NeoTx) and patent licensing (Novartis). The remaining authors declare no competing interests.